 | Arbutus Biopharma (NASDAQ:ABUS) Now Covered by Jefferies Financial Group
marketbeat.com - February 25 at 7:54 AM |
 | Arbutus Biopharma (NASDAQ:ABUS) Trading 5.1% Higher
americanbankingnews.com - March 5 at 8:48 PM |
| Arbutus Biopharma (NASDAQ:ABUS) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS
americanbankingnews.com - March 5 at 10:54 AM |
| Arbutus Biopharma (NASDAQ:ABUS) Shares Down 13.7%
americanbankingnews.com - March 4 at 9:35 PM |
 | Recap: Arbutus Biopharma Q4 Earnings
benzinga.com - March 4 at 9:07 AM |
 | Arbutus Biopharma Corp. to Host Earnings Call
finance.yahoo.com - March 4 at 9:07 AM |
| Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - March 4 at 9:07 AM |
| Earnings Preview: Arbutus Biopharma
finance.yahoo.com - March 3 at 5:59 PM |
| Is a Surprise Coming for Arbutus Biopharma (ABUS) This Earnings Season?
finance.yahoo.com - March 3 at 12:58 PM |
| Zacks: Analysts Expect Arbutus Biopharma Co. (NASDAQ:ABUS) to Announce -$0.23 EPS
americanbankingnews.com - March 2 at 10:14 PM |
|
| Arbutus to Participate at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 9:55 AM |
| Arbutus Biopharma (NASDAQ:ABUS) Coverage Initiated at Jefferies Financial Group
americanbankingnews.com - February 25 at 9:02 AM |
| Arbutus Biopharma (ABUS) to Release Earnings on Thursday
americanbankingnews.com - February 25 at 2:10 AM |
| Arbutus Biopharma (NASDAQ:ABUS) Trading 15.4% Higher
americanbankingnews.com - February 24 at 7:20 PM |
| Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 10.7%
americanbankingnews.com - February 23 at 8:32 PM |
| Arbutus to Report Fourth Quarter and Year End 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - February 22 at 9:00 AM |
| Arbutus Biopharma Co. (NASDAQ:ABUS) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - February 19 at 9:10 AM |
| Here's What Arbutus Biopharma Corporation's (NASDAQ:ABUS) Shareholder Ownership Structure Looks Like
finance.yahoo.com - February 15 at 9:40 AM |
 | ABUS Feb 2021 5.000 call
uk.finance.yahoo.com - January 26 at 7:18 PM |
 | Arbutus: A Promising Pure-Play On The $2.13 Billion Global Hepatitis B Market
seekingalpha.com - January 26 at 7:18 PM |
| Arbutus Announces 2021 Corporate Objectives and Provides Financial Update
finance.yahoo.com - January 25 at 8:42 AM |
| ABUS Feb 2021 7.500 call
uk.finance.yahoo.com - January 23 at 7:01 PM |
| ABUS Jan 2021 10.000 put
uk.finance.yahoo.com - January 13 at 11:02 PM |
| Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright BioConnect 2021 Conference
finance.yahoo.com - January 4 at 8:30 AM |
| Are Investors Undervaluing Arbutus Biopharma Corporation (NASDAQ:ABUS) By 26%?
finance.yahoo.com - January 1 at 8:24 AM |
 | Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
marketwatch.com - December 15 at 12:35 PM |
| Is ABUS A Good Stock To Buy Now?
finance.yahoo.com - December 12 at 6:59 PM |
| Thinking about buying stock in Pfizer, Rewalk Robotics, Veru, Arbutus Biopharma, or Plug Power?
marketwatch.com - December 10 at 2:30 PM |
| Arbutus Announces Robust HBsAg Decline Data with AB-729 Dosed at 60 mg Every 8 Weeks in Chronic Hepatitis B Subjects
finance.yahoo.com - December 10 at 2:30 PM |
| ABUS Dec 2020 10.000 put
au.finance.yahoo.com - November 29 at 4:15 PM |
| Arbutus' AB-729 shows encouraging results in chronic hepatitis B
seekingalpha.com - November 16 at 10:01 AM |
| Arbutus Announces Additional Robust HBsAg Decline Data with AB-729 in Chronic Hepatitis B Subjects
finance.yahoo.com - November 16 at 10:01 AM |
|
| Implied Volatility Surging for Arbutus Biopharma (ABUS) Stock Options
finance.yahoo.com - November 12 at 1:49 PM |
| Arbutus to Present at Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 10 at 9:00 AM |
 | Earnings Update: Arbutus Biopharma Corporation (NASDAQ:ABUS) Just Reported And Analysts Are Trimming Their Forecasts
nasdaq.com - November 7 at 12:18 PM |
| Arbutus Biopharma Corporation (NASDAQ:ABUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 7 at 7:17 AM |
| Arbutus Biopharma Corporation (ABUS) CEO Bill Collier on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 5:29 PM |
| Arbutus Biopharma EPS misses by $0.05, misses on revenue
seekingalpha.com - November 5 at 12:29 PM |
| Return On Capital Employed Overview: Arbutus Biopharma
benzinga.com - November 4 at 11:26 AM |
| We're Keeping An Eye On Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Rate
finance.yahoo.com - October 16 at 2:13 PM |
| Arbutus to Participate in Virtual Fireside Chat at Chardan's 4th Annual Genetic Medicines Conference
marketwatch.com - September 28 at 11:27 PM |
| Thinking about buying stock in Arbutus Biopharma, TRACON Pharmaceuticals, Workhorse Group, Trevena, or Cassava Sciences?
marketwatch.com - September 17 at 5:43 PM |
 | Why Arbutus Stock Is Trading Higher Today
msn.com - September 15 at 12:25 PM |
| Arbutus' AB-729 shows positive action in HBV study
seekingalpha.com - September 15 at 12:25 PM |
 | Bucks County firm's stock surges on positive study data for hepatitis B therapy
bizjournals.com - September 15 at 12:25 PM |
| Arbutus Announces AB-729 90 mg Single-Dose Week 12 Data in Chronic Hepatitis B Subjects Demonstrating Significant and Continuous Reductions in HBsAg
finance.yahoo.com - September 15 at 12:25 PM |
| Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 9 at 9:15 AM |
| As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval
msn.com - September 4 at 6:15 PM |
| Ebola Treatment Market Analysis and Global Research Report 2020 to 2026
marketwatch.com - August 28 at 4:59 AM |
| Assembly Biosciences teams up with Arbutus Biopharma in chronic HBV infection
seekingalpha.com - August 27 at 8:49 AM |
| Assembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement to Evaluate the Combination of Core Inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in Patients with Chronic Hepatitis B Virus Infection
finance.yahoo.com - August 27 at 8:49 AM |
